GGrantIndex
← Leaderboards

Samuel A Shelburne

Methodist Hospital Research Institute

$8,822,845
Attributed
$9,272,790
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,311,202 · 11

By mechanism

P01$14,563,497 · 2
R01$3,561,040 · 2
R21$2,694,467 · 6
K08$492,198 · 1

Top collaborators

Most similar at Methodist Hospital Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionPathogenPathogenesisMediatingBaseGenesInvestigationStreptococcus PyogenesInsightBacteriaProteinsSiteTranscriptGene ExpressionVirulenceVirulence FactorsCharacteristicsLaboratoriesDesignCohortAffectAnimal ModelProductionMolecular

Grant awards (37)

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,377,848
P01 · FY2025 · AI
Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens$474,264
P01 · FY2025 · AI · contact PI
Delineation of mechanisms underlying response regulator activation in group A Streptococcus$196,425
R21 · FY2025 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,406,527
P01 · FY2024 · AI
Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens$474,261
P01 · FY2024 · AI · contact PI
Delineation of mechanisms underlying response regulator activation in group A Streptococcus$243,000
R21 · FY2024 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,411,532
P01 · FY2022 · AI
Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens$543,142
P01 · FY2022 · AI · contact PI
Impact of regulatory cross-talk on the pathophysiology of emergent acapsular group A streptococcus$202,500
R21 · FY2022 · AI · contact PI
Role of β-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae$199,573
R21 · FY2022 · AI · contact PI
Defining novel mechanisms of clonal emergence in Group A Streptococcus$198,750
R21 · FY2022 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,378,848
P01 · FY2021 · AI
Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens$480,000
P01 · FY2021 · AI · contact PI
Role of response regulator phosphorylation in group A streptococcal pathogenesis$400,000
R01 · FY2021 · AI · contact PI
Role of β-lactamase encoding gene amplification in the development of non-carbapenemase producing, carbapenem-resistant Enterobacteriaceae$270,079
R21 · FY2021 · AI · contact PI
Defining novel mechanisms of clonal emergence in Group A Streptococcus$254,000
R21 · FY2021 · AI · contact PI
Impact of regulatory cross-talk on the pathophysiology of emergent acapsular group A streptococcus$243,000
R21 · FY2021 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,463,657
P01 · FY2020 · AI
Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens$553,418
P01 · FY2020 · AI · contact PI
Role of response regulator phosphorylation in group A streptococcal pathogenesis$400,000
R01 · FY2020 · AI · contact PI
Impact of a novel emm-enn gene fusion event on epidemic behavior of group A streptococcus$196,820
R21 · FY2020 · AI · contact PI
Role of response regulator phosphorylation in group A streptococcal pathogenesis$400,000
R01 · FY2019 · AI · contact PI
Impact of a novel emm-enn gene fusion event on epidemic behavior of group A streptococcus$250,320
R21 · FY2019 · AI · contact PI
Novel mechanisms of emergence of hypervirulent group A Streptococcus$200,000
R21 · FY2019 · AI · contact PI
Role of response regulator phosphorylation in group A streptococcal pathogenesis$400,000
R01 · FY2018 · AI · contact PI
Novel mechanisms of emergence of hypervirulent group A Streptococcus$240,000
R21 · FY2018 · AI · contact PI
Role of response regulator phosphorylation in group A streptococcal pathogenesis$400,000
R01 · FY2017 · AI · contact PI
Contribution of catabolite control protein A to group A streptococcal virulence$316,000
R01 · FY2015 · AI · contact PI
Contribution of catabolite control protein A to group A streptococcal virulence$316,000
R01 · FY2014 · AI · contact PI
Contribution of catabolite control protein A to group A streptococcal virulence$297,040
R01 · FY2013 · AI · contact PI
Contribution of catabolite control protein A to group A streptococcal virulence$316,000
R01 · FY2012 · AI · contact PI
Contribution of catabolite control protein A to group A streptococcal virulence$316,000
R01 · FY2011 · AI · contact PI
Analysis Of Group A Streptococcus-Saliva Interaction$125,280
K08 · FY2009 · AI · contact PI
Analysis Of Group A Streptococcus-Saliva Interaction$123,120
K08 · FY2008 · AI · contact PI
Analysis Of Group A Streptococcus-Saliva Interaction$3,478
K08 · FY2008 · AI · contact PI
Analysis Of Group A Streptococcus-Saliva Interaction$125,899
K08 · FY2007 · AI · contact PI
ANALYSIS OF GROUP A STREPTOCCUS-SALIVA INTERACTION$114,421
K08 · FY2006 · AI · contact PI